Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 257 followers
Latest posts
Last updated about 11 hours ago
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation...
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed
about 11 hours ago
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation...
Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium bromide, Date of authorisation: 28/04/2014, Revision: 21, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium...
Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation...
Human medicines European public assessment report (EPAR): Winrevair, Sotatercept, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Winrevair, Sotatercept, Date of authorisation...
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 14, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium...
Human medicines European public assessment report (EPAR): Cinainu, dry aqueous extract of paullinia cupana seed,dry hydroethanolic extract of theobroma cacao seed,liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh
about 16 hours ago
Human medicines European public assessment report (EPAR): Cinainu, dry aqueous extract of...
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Status: Opinion
about 16 hours ago
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Status: Opinion
5 months ago
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 20, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium...
Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium...
Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date of authorisation: 20/08/2015, Revision: 15, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Respreeza, alpha1-proteinase inhibitor (human), Date...